These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37981052)

  • 1. Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
    Sun Y; Lu Z; Taylor JA; Au JLS
    J Control Release; 2024 Jan; 365():89-100. PubMed ID: 37981052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
    Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
    Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecto-calreticulin in immunogenic chemotherapy.
    Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
    Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment.
    Kim DY; Pyo A; Yun M; Thangam R; You SH; Zhang Y; Jung YR; Nguyen DH; Venu A; Kim HS; Yoon MS; Hong Y; Min JJ
    J Nucl Med; 2021 Jul; 62(7):956-960. PubMed ID: 33509975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
    Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
    Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
    Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
    Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines.
    Huang Y; Dong Y; Zhao J; Zhang L; Kong L; Lu JJ
    Ann Transl Med; 2019 Oct; 7(20):542. PubMed ID: 31807524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
    Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
    Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
    Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy.
    Zhang Y; Thangam R; You SH; Sultonova RD; Venu A; Min JJ; Hong Y
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Roles of Calreticulin in Cancer: Implications for Therapy.
    Venkateswaran K; Verma A; Bhatt AN; Shrivastava A; Manda K; Raj HG; Prasad A; Len C; Parmar VS; Dwarakanath BS
    Curr Protein Pept Sci; 2018 Feb; 19(4):344-357. PubMed ID: 28079009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-stage inhibition of autophagy enhances calreticulin surface exposure.
    Li DD; Xie B; Wu XJ; Li JJ; Ding Y; Wen XZ; Zhang X; Zhu SG; Liu W; Zhang XS; Peng RQ
    Oncotarget; 2016 Dec; 7(49):80842-80854. PubMed ID: 27825129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy.
    Zhang Y; Akhil V; Seo HS; Park HR; Kim SH; You SH; Liu Z; Kim SY; Sultonova RD; Min JJ; Hong Y
    Theranostics; 2024; 14(3):1195-1211. PubMed ID: 38323311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity.
    Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A
    Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098
    [No Abstract]   [Full Text] [Related]  

  • 15. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
    Obeid M
    J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin as a marker and therapeutic target for cancer.
    Zhang M; Xiao J; Liu J; Bai X; Zeng X; Zhang Z; Liu F
    Clin Exp Med; 2023 Sep; 23(5):1393-1404. PubMed ID: 36335525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.
    Furukawa R; Inoue H; Yoneshima Y; Tsutsumi H; Iwama E; Ikematsu Y; Ando N; Shiraishi Y; Ota K; Tanaka K; Nakanishi Y; Okamoto I
    Lung Cancer; 2021 May; 155():144-150. PubMed ID: 33819860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
    Sen Santara S; Lee DJ; Crespo Â; Hu JJ; Walker C; Ma X; Zhang Y; Chowdhury S; Meza-Sosa KF; Lewandrowski M; Zhang H; Rowe M; McClelland A; Wu H; Junqueira C; Lieberman J
    Nature; 2023 Apr; 616(7956):348-356. PubMed ID: 37020026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
    Kielbik M; Szulc-Kielbik I; Klink M
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
    Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
    Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.